Senior insider sale
Chief Technology Officer at VIR BIOTECHNOLOGY, INC. — senior position signals high conviction
$133.9K
14.17K shares
What this filing means
HANLY ANN M. plans to sell 14.17K shares of VIR BIOTECHNOLOGY, INC. valued at approximately $133.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/24/2025ACC: 0001628280-25-007539
Officer· Chief Technology Officer
Since Mar 2021
14.17K
Shares to sell
$133.9K
Approx. market value
37.54K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
2/22/2025
37.54KTotal acquired37.54K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/22/2025 | Restricted Stock Units N/A | 37.54K | — |
| Total | 37.54K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
14.17K
Market value
$133.9K
2/24/2025
Total
Units
14.17K
Value
$133.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
2/24/2025 | 14.17K | $133.9K | NASDAQ | Planned |
| Total | 14.17K | $133.9K | ||